The Journal of dermatology
-
Comparative Study Clinical Trial
Safety of selective cyclooxygenase-2 inhibitors and a basic non-steroidal anti-inflammatory drug (NSAID) in Japanese patients with NSAID-induced urticaria and/or angioedema: Comparison of meloxicam, etodolac and tiaramide.
The identification of a safe and reliable alternative for patients with non-steroidal anti-inflammatory drug (NSAID)-induced urticaria/angioedema is a frequent problem for dermatologists and other practitioners. Cyclooxygenase-2 (COX-2) inhibitors have been reported to be safe for NSAID-intolerant patients from the US and Europe but not all of them have yet been approved for use in Japan. It was our objective to investigate the clinical manifestations of oral NSAID challenges in Japanese patients with histories of urticaria and/or angioedema after the intake of NSAIDs and to find safe alternative drugs, including COX-2 inhibitors and a basic anti-inflammatory drug. ⋯ Skin prick tests with NSAIDs were 100% negative. This study showed that among the NSAIDs that are available in Japan and that were investigated in this study, tiaramide, which does not inhibit COX, is the relatively safe alternative drug for Japanese patients with NSAID-induced urtiacaria and/or angioedema. Furthermore, meloxicam seems to be better tolerated than etodolac between two selective COX-2 inhibitors.
-
At first consultation, it is sometimes difficult for patients to decide which questions they want to ask most. We investigated whether an improvement in interview forms would identify the questions that patients want to ask doctors and help patients express their needs. First, we developed a two-part interview form specifically for atopic dermatitis (AD) patients. ⋯ The majority of them recognized the necessity for and usefulness of these tools to communicate appropriately with their doctors. The answer brochure significantly increased their understanding of AD. The AD-specific interview form and the answer brochure are useful communication tools to improve doctor-patient relationships.